MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 159 filers reported holding MERSANA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14 | -93.5% | 11,270 | -82.9% | 0.00% | – |
| Q2 2023 | $216 | +15.5% | 65,850 | +44.6% | 0.00% | – |
| Q1 2023 | $187 | +938.9% | 45,542 | +1373.9% | 0.00% | – |
| Q4 2022 | $18 | -99.8% | 3,090 | +148.2% | 0.00% | – |
| Q3 2022 | $8,000 | -88.1% | 1,245 | -91.5% | 0.00% | – |
| Q2 2022 | $67,000 | -1.5% | 14,683 | -14.5% | 0.00% | – |
| Q1 2022 | $68,000 | +3300.0% | 17,180 | +9830.6% | 0.00% | – |
| Q3 2021 | $2,000 | -33.3% | 173 | -36.6% | 0.00% | – |
| Q2 2021 | $3,000 | -81.2% | 273 | -73.4% | 0.00% | – |
| Q1 2021 | $16,000 | -71.9% | 1,028 | -52.0% | 0.00% | – |
| Q4 2020 | $57,000 | +39.0% | 2,143 | +20.8% | 0.00% | – |
| Q2 2020 | $41,000 | – | 1,774 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |